Carney’s big federal budget bets

In the wake of the Democratic sweep of the U.S. midterms, we take a deeper look at the factors that got us here, from Iran to data centres. We also examine what could come next from a rejected Republican Party and a blue Congress.David A. Graham joins us. He's a staff writer at T ...  Afficher plus

Trump-backed picks lost and Republican strongholds crumbled as Democrats won control of both the House and the Senate. Alex Shephard, senior editor at The New Republic, is here. We talk about some of the stunning Democrat wins, like Texas and South Carolina. How will they wield t ...  Afficher plus

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Afficher plus

UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ...  Afficher plus

American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ...  Afficher plus